The Events Calendar

The calendar includes details of all OBN Events and a selection of non-OBN Events as suggested by OBN Members or a variety of other sources.

Outline information can be viewed by hovering; clicking takes you to the details.  Please use the "Calendar View" button below to return to calendar overview, rather than your browser's 'back' button.

The calendar view can be filtered and/or displayed as a list using the various buttons.

OBN BioTuesday: What’s New in Antimicrobial Resistance – is there light at the end of the tunnel?

Event Start Date: Tuesday, July 16, 2019 5:30 PM

Event End Date: Tuesday, July 16, 2019 9:30 PM

Event Locations
Manchester
Cost: £0.00

OBN BioTuesday: What’s New in Antimicrobial Resistance – is there light at the end of the tunnel?

 

The development of resistance to antimicrobials threatens to reverse the changes in public health that have occurred over the last 70 years or so. This is a global problem. While it is tempting to feel relatively comfortable with the situation, living as we do in the Western World, unless antimicrobial resistance (AMR) is tackled, it is very likely at some point to wreak havoc here too. Who now doesn’t regard the risk of a hospital acquired infection in themselves, a friend or a relative as a significant possibility? Or who now is not more concerned over minor cuts and grazes?

 

AMR is a much-discussed topic, and this edition of our BioTuesday series aims to provide attendees a better understanding of a range of issues, including the factors holding the development of new medicines back and how the field will develop.

 

Our speakers will discuss matters such as:

 

  • The background to the crisis of AMR
  • Has the situation worsened due to a lack of education and early action?
  • What are the latest government policies around AMR – is this enough?
  • What is the government and private funding landscape like for AMR research?
  • What role does Machine Learning plan in the research of potential solutions to this crisis?
  • Where does the UK stand compared to the rest of the world?
  • How does the use of antibiotics in farming impact the problem, and what is the farming industry doing to make the required changes?
  • What needs to change to get big pharma engaged?
  • Is a combination approach the answer to AMR?

 

PROGRAMME

17:30   Registration & Networking

18:00   Welcome & Introductions

John Harris, CEO, OBN

Geoff Davison, CEO, BioNow

Chris Doherty, Managing Director, Alderley Park

18:15   Keynote Presentations

Dr Peter Jackson, Executive Director, AMR Centre

Dr Fiona Marston, Director of the Centre of Excellence in Infectious Diseases Research

Dr Richard Fitzgerald, Director of The Royal Liverpool and Broadgreen University Hospitals NHS Trust 

Dr Peter Warn, SVP Anti-infective Discovery, Evotec

19:15   Company Presentations

Dr Deborah O'Neil, CEO, NovaBiotics 

Dr Fiona Rudkin, CEO, mycoBiologics 

Heather Graz, Commercial Development Manager, Neem Biotech 

Conrad Lichtenstein, CSO, Nemesis Bioscience 

Neill Gingle, Head of Research, metaLinear

William Rhys-Williams, Senior Director of Operations, Destiny Pharma 

Clive Mason, Senior Director - Anti-infectives Research, Summit Therapeutics

20:25   Q&A with speakers and audience, hosted by Chris Doherty

20:40   Networking with drinks and canapes served

 

VENUE

Alderley Park Conference Centre, Nether Alderley, Macclesfield, SK10 4TG

 

TICKETS

OBN Members - Complimentary

R&D companies - Complimentary

PHD Students & Research Scientists - Complimentary

Non Members, Non R&D Companies - £50+VAT

 

This event is kindly co-promoted by BIONOW